Helicobacter pylorieradication therapy: indications, efficacy and safety
- 8 May 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Safety
- Vol. 7 (3), 271-281
- https://doi.org/10.1517/14740338.7.3.271
Abstract
Background: Helicobacter pylori infects up to half of the world's population. It remains the major cause of peptic ulcer disease and is recognised as a carcinogen for its role in gastric carcinogenesis. Successful eradication of the bacteria is associated with improved health outcomes including fewer dyspeptic symptoms, reduced peptic ulcer recurrence and rebleeding, reduced peptic ulcer risk with NSAIDs and as a cure for low-grade gastric MALT lymphoma. The risk of gastric cancer is reduced in those without premalignant mucosal abnormalities at the time of eradication. Objective: This review outlines the current indications and options for therapy of H. pylori with particular reference to drug-induced adverse events associated with treatment. Methods: The indications for H. pylori eradication are evidence-based and in accordance with recent consensus statements and recommendations. The eradication treatment is based on numerous clinical trials and meta-analyses. Results/conclusion: Eradication therapy, i...Keywords
This publication has 82 references indexed in Scilit:
- Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus ReportGut, 2007
- Meta‐analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID usersAlimentary Pharmacology & Therapeutics, 2005
- The effect of Helicobacter pylori and its eradication on gastro‐oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitisAlimentary Pharmacology & Therapeutics, 2004
- Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic AnalysisThe American Journal of Gastroenterology, 2004
- A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE studyGastroenterology, 2002
- Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysisThe Lancet, 2002
- Helicobacter pylori and nonsteroidal anti-inflammatory drugs. Approaching the end of the controversy in the new millennium, or room for more debate?The Esophagus, 2001
- Preventing Recurrent Upper Gastrointestinal Bleeding in Patients withHelicobacter pyloriInfection Who Are Taking Low-Dose Aspirin or NaproxenNew England Journal of Medicine, 2001
- Editorial: Can Therapy Ever Be Denied for Helicobacter pylori Infection?Gastroenterology, 1997
- Helicobacter pyloriInfection and DyspepsiaScandinavian Journal of Gastroenterology, 1996